Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
Key1 Capital is a global investment firm primarily focused on Israeli and Israeli-related growth technology companies. The firm aims to partner with and support entrepreneurs and founders as they transform their businesses into global leaders. They provide strategic venture capital for defense tech, AI, and enterprise software, offering global connections and support for organic and inorganic growth, as well as strategic planning for exits.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is Key Capital's primary investment focus by sector?
- Key Capital has invested in the Health Tech & Life Sciences sector, with one portfolio company in this area.
- What is Key Capital's typical investment stage?
- Key Capital has participated in a Convertible Debt round, indicating an investment in early-stage companies.
- When was Key Capital's most recent investment activity?
- Key Capital's most recent investment round occurred in March 2021.
- Can you name a notable company in Key Capital's portfolio?
- Key Capital's portfolio includes EPM, a company focused on steroid substitutes based on synthetic cannabinoid acids.
- What was the funding stage and amount for EPM?
- EPM received Seed funding, raising $2.5M, with Key Capital participating in a Convertible Debt round.
- What is Key Capital's investment range?
- Key Capital's investment range is between $1M and $1M.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2022-1 |
|---|
Radar intelligence
Patents
| EPO | 3 |
|---|